RHI is proud to have its CEO, Bill Barrable, speak at the following session:
Visionary Plenary Session - Transforming Discovery into Opportunity: Innovative Partnership Models to
De-risk Early-Stage Investment, and Translate Research into Products
Date: February 25, 2013
Time: 13:00 – 14:30
Location: West Ballroom A, 1st Floor, Vancouver Convention Centre, Vancouver, BC CANADA
As getting new drugs and other therapeutic products to market becomes more and more difficult, and the associated costs and risks become greater and greater, the various players in this equation (from academic institutions and granting agencies to translational research organizations to foundations and industry) must find new ways to come together to support innovation by effectively de-risking new technologies, and filling the gaps in the development continuum. In this context, this session will provide case studies on British Columbia’s ecosystem for fostering pre-competitive research, and translating that research into new therapies for patients through unique public-private partnership models. (For more on RHI’s commercialization strategy, please read our latest CEO Update.)
Chair: Dr. Diane Finegood, President and CEO, Michael Smith Foundation for Health Research
- Speaker: Mr. Bill Barrable, CEO, Rick Hansen Institute
- Speaker: Mrs. Karimah Es Sabar, President and CEO, The Centre for Drug Research and Development (CDRD)
- Speaker: Dr. Martin Gleave, Vancouver Prostate Centre & OncoGenex Pharmaceuticals
- Speaker: Dr. Rav Kumar, Vice President, GlaxoSmithKline Inc.
- Speaker: Dr. Alan Winter, CEO, Genome British Columbia
- Speaker: Dr. Steven Xanthoudakis, Director, World Wide Licensing and External Research, Merck & Co Inc.
Produced by TVG, PR1ME and LifeSciences British Columbia, BioPartnering North America™ (BPN) is the only global life sciences conference in Canada. For more information on BPN, please visit http://www.techvision.com/bpn/.
The Rick Hansen Institute
The Rick Hansen Institute (RHI) is a Canadian-based not-for-profit organization committed to accelerating the translation of discoveries and best practices into improved treatments for people with spinal cord injuries. It does this by leading the collaboration of researchers, health care professionals and service providers across Canada and internationally. RHI has matched leadership and research collaboration with government funding to facilitate one of the largest interdisciplinary spinal cord injury research programs in the world. For more information, please visit: www.rickhanseninstitute.org.